Understand the source comparison
Tesofensine Energy Complete Guide 2026: Metabolic vs Cognitive Effects Comparison
Resting Energy Expenditure Increase Beta-3 adrenergic receptor activation via sustained norepinephrine elevation 7–14 days 6–10% above baseline at steady state (week 3–4) Returns to baseline within 10–14 days post-cessation Measurable via indirect calorimetry;
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Resting Energy Expenditure Increase
- Beta-3 adrenergic receptor activation via sustained norepinephrine elevation
- 7–14 days
- 6–10% above baseline at steady state (week 3–4)
- Returns to baseline within 10–14 days post-cessation
- Measurable via indirect calorimetry; effect persists only while dosing continues
- Subjective Alertness
- Locus coeruleus norepinephrine projection to cortex + dopamine elevation in prefrontal cortex
- 2–4 days
- Stabilizes by week 2–3 as homeostatic adaptation occurs
- Declines gradually over 5–7 days due to long half-life
- Most pronounced in first two weeks; sustained but less dramatic thereafter
- Cognitive Clarity / Focus
- Dopamine and norepinephrine modulation of working memory circuits in DLPFC
- 3–7 days
- Maximal during weeks 2–4
- Fades over 7–10 days post-cessation
- Dose-dependent; optimal at 0.5mg; overstimulation risk at 1.0mg
- Appetite Suppression
- Triple monoamine elevation reducing orexigenic signaling in hypothalamus
- 1–3 days
- Strongest during titration phase; tolerance develops partially by week 6–8
- Returns within 3–5 days after stopping
- Secondary to energy effect; not the primary mechanism for metabolic rate increase